%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-10-23T20:42:32+03:00
2013-10-23T20:42:32+03:00
2013-10-23T20:42:32+03:00
application/pdf
bs-7580R-PE-Cy3
uuid:d47971d0-4e4c-4df2-a39e-6eba74125bb2
uuid:0d2f43c0-db1f-45d3-8342-f9c8c995fd8d
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[31 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.679 574.5 -733.348 re
f
BT
0.2 scn
/TT0 1 Tf
6.6187 0 0 6.6187 21.2517 767.3623 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw 0 -1.5 TD
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
140.9775391 0 0 -79.4239655 443.5224762 810.3836365 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2661 0 0 9.2661 21.2517 715.7368 Tm
[(bs)-67(-)-69(7580R)-12(-)-69(PE)-14(-)-69(Cy3)]TJ
/TT0 1 Tf
-0.04 Tw 7.2805 0 0 7.2805 28.5323 669.4061 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Inhibits)-84( NF)-85(-)-1(kappa)-73(-)-1(B)-47( activation)-37( triggered)-6( by)-40( overexpression)-27( of)-48( RIPK1)-48( and TRAF6)-37( but)-9( not)-20( of)-48( RELA.)-53( Inhibits)-84( also)]TJ
0 -1.455 TD
[(tumor)-1( necrosis)-67( \(TNF\),)-68( IL)-38(-)-1(1)-90( and TLR4)-24(-)-1(induced)-17( NF)-85(-)-1(kappa)-73(-)-1(B)-47( activation)-37( in)-31( a)-20( dose)-23(-)-1(dependent)-40( manner.)]TJ
0 -1.455 TD
[(Overexpression)-44( sensitizes)-89( cells)-18( to)-32( TNF)-46(-)-1(induced)-16( apoptosis.)-70( Could)-61( be)-12( involved)-2( in)-31( regulating)-30( NF)-85(-)-1(kappa)-73(-)-1(B)-47( activation)]TJ
0 -1.455 TD
[(and apoptosis.)-70( Is)-90( a)-20( potent)-61( inhibitory factor)-4( for)-52( osteoclast)-68( differentiation.)-11( Involved)-40( in)-31( protein)-79( degradation)-14( via)-21( the)]TJ
T*
[(ubiquitin)-17(-)-1(proteasome)-77( system)-92( and plays)-22( a)-20( critical)-81( role)-69( in)-31( muscle)-31( atrophy.)-53( May)-24( act)-44( by)-40( anchoring)-19( ubiquitinylated)]TJ
0 -1.455 TD
[(proteins)-87( to)-32( the)-36( proteasome,)-46( playing)-37( a)-20( critical)-81( role)-69( in)-31( protein)-79( degradation.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Aqueous)-34( buffered)-15( solution)-14( containing)-88( 100ug/ml)-73( BSA,)-42( 50%)-22( glycerol)-56( and less)-80( than)-25( 0.09%)-82( sodium)-13( azide.)-56( Store)-44( at)-50( -)]TJ
0 -1.455 TD
[(20\260C)-18( for)-52( 12)-90( months.)-54( Protect)-73( from)-30( light.)-67( [Product)-75( without)-66( BSA)-72( and/or)-79( sodium)-13( azide)-87( is)-52( available)-70( for)-52( special)-31( order.])]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-37( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-36( package.)]TJ
/TT1 1 Tf
0 Tw 54.182 28.364 Td
(Size:)Tj
/TT0 1 Tf
3 -0.091 Td
(100ul)Tj
/TT1 1 Tf
-3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.6187 0 0 6.6187 423.0046 623.7373 Tm
(Human,Mouse,Rat,Chicken,Pig,Bovine,Rabbit,Sheep,)Tj
0 scn
/TT1 1 Tf
7.2805 0 0 7.2805 423.0046 609.8381 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.9326 592.2987 cm
0 0 m
0 1.324 -1.986 1.324 -1.986 0 c
-1.986 -1.324 0 -1.324 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2805 0 0 7.2805 439.5513 590.644 Tm
[(IF\(1:100)-3(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.9326 581.7088 cm
0 0 m
0 1.324 -1.986 1.324 -1.986 0 c
-1.986 -1.324 0 -1.324 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.2805 0 0 7.2805 439.5513 580.0541 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)]TJ
T*
[(Optimal)-36( working)-62( dilutions)-48( must)-4( be)]TJ
0 -1.455 TD
[(determined)-86( by)-40( the)-36( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.6187 0 0 6.6187 466.0259 516.515 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.2805 0 0 7.2805 423.0046 502.6158 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.6187 0 0 6.6187 501.7667 502.6158 Tm
(23kDa)Tj
0 scn
/TT1 1 Tf
7.2805 0 0 7.2805 423.0046 488.7166 Tm
(Note:)Tj
/TT0 1 Tf
0.021 Tw 5.9568 0 0 5.9568 423.0046 461.58 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
562.5863953 0 0 -0.6618652 18.6042633 707.1324768 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.5899 0 0 10.5899 21.2517 84.3162 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 19.2661 691.9095 cm
0 0 m
0 1.765 -2.647 1.765 -2.647 0 c
-2.647 -1.765 0 -1.765 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2661 0 0 9.2661 28.5323 689.2621 Tm
[(Rabbit)-50( Anti)-28(-)-69(ZFAND5)-17( Polyclonal)-4( Antibody,)-47( PE)-14(-)-69(Cy3)-49( conjugated)]TJ
ET
q
/GS0 gs
99.279953 0 0 -74.7908936 25.2229309 396.7171631 cm
/Im2 Do
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
0 Tw 10.5899 0 0 10.5899 25.2229 312.6601 Tm
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-0.04 Tw 7.2805 0 0 7.2805 26.5467 233.2362 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.6187 0 0 6.6187 180.0997 233.2362 Tm
(HERE)Tj
/CS0 cs 0 scn
7.2805 0 0 7.2805 196.6463 233.2362 Tm
(.)Tj
ET
q
/GS0 gs
0.6618652 0 0 -595.679718 409.105423 706.4705963 cm
/Im3 Do
Q
q
/GS0 gs
5.9568024 0 0 -40.3738556 578.5432129 122.704483 cm
/Im4 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(ײ{~88M)
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L